Ovarian cancer immunotherapy with an oncolytic adenovirus and checkpoint inhibition: Biological analyses of patient samples from a phase 1 clinical trial
Starting year
2023
Granted funding
Akseli Hemminki 
50 000 €
Funder
Cancer Foundation Finland sr.
Other information
Funding decision number
A2642
Fields of science
Cancers
Identified topics
cancer